ArticleCancers2021

Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder.

Line H Dohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.